CURLF vs USNA
Curaleaf Holdings, Inc. and Usana Health Sciences Inc., side by side — 5 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | CURLF | USNA |
|---|---|---|
| Revenue | $1.3B | $925.3M |
| Net income | $-231.1M | $10.8M |
| Gross margin | 49.8% | 78.3% |
| Net margin | −18.0% | 1.2% |
| Return on equity | −28.6% | 2.0% |
| Diluted EPS | −$0.35 | $0.58 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | $74.3M | $8.5M |
| Equity | $756.4M | $533.1M |
| Net debt / equity | 0.59× | · |
| Current ratio | 1.52× | 2.24× |
| Revenue CAGR 5y | · | −4.0% |
| Profit CAGR 5y | · | −38.7% |
CURLF bills 1.4× the revenue of USNA, and CURLF closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
5 years side by side
| Fiscal year | CURLF | USNA |
|---|---|---|
| FY2025 | $1.3B | $925.3M |
| FY2024 | $1.3B | $854.5M |
| FY2023 | $1.3B | $921.0M |
| FY2022 | $1.3B | $998.6M |
| FY2021 | $1.2B | $1.2B |
Bottom line
| Fiscal year | CURLF | USNA |
|---|---|---|
| FY2025 | $-231.1M | $10.8M |
| FY2024 | $-215.4M | $42.0M |
| FY2023 | $-281.2M | $63.8M |
| FY2022 | $-370.1M | $69.3M |
| FY2021 | $-205.9M | $116.5M |
5 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$342,878,000 | CURLF |
| FY2024 | +$479,796,000 | CURLF |
| FY2023 | +$425,622,000 | CURLF |
| FY2022 | +$276,819,000 | CURLF |
| FY2021 | +$9,523,000 | CURLF |
CURLF has reported the higher revenue in every one of these 5 fiscal years. The gap has widened since the earliest year compared.
5 of 17 comparable fiscal years — a year missing data on either side is not counted.
5 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | −19.2 pp | USNA |
| FY2024 | −21.6 pp | USNA |
| FY2023 | −28.5 pp | USNA |
| FY2022 | −36.5 pp | USNA |
| FY2021 | −27.8 pp | USNA |
USNA has kept the higher net margin in every one of these 5 fiscal years.
5 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
CURLF's net margin has been more volatile than USNA's over the 5 comparable fiscal years — 4.7 percentage points of standard deviation against 2.8.
5 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
USNA led in net margin in every one of the 5 comparable fiscal years — a structural lead, not a recent swing.
5 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
USNA's return on equity has been more volatile than CURLF's over the 5 comparable fiscal years — 8.7 percentage points of standard deviation against 5.2.
5 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
USNA led in return on equity in every one of the 5 comparable fiscal years — a structural lead, not a recent swing.
5 of 17 comparable fiscal years — a year missing data on either side is not counted.